×
For best experience we recommend to activate Javascript in your browser.
LYVE1 antibody (AA 26-131)
This Rabbit Polyclonal antibody specifically detects LYVE1 in WB, ELISA and IHC. It exhibits reactivity toward Human.
Quick Overview for LYVE1 antibody (AA 26-131) (ABIN7570136)
Target
See all LYVE1 Antibodies
LYVE1
(Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
Reactivity
All reactivities for LYVE1 antibodies
Human
Host
All hosts for LYVE1 antibodies
Rabbit
Clonality
All clonalities for LYVE1 antibodies
Polyclonal
Conjugate
All conjugates for LYVE1 antibodies
This LYVE1 antibody is un-conjugated
Application
All applications for LYVE1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-LYVE1 Antibody
(hide)
Binding Specificity
All epitopes for LYVE1 antibodies
AA 26-131
Purpose
Anti-Human LYVE1 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human LYVE1 (Arg26-Ser131).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for LYVE1
(hide)
Target
LYVE1
(Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
Alternative Name
LYVE1
Background
Cell surface retention sequence-binding protein 1, XLKD1, LYVE-1, Hyaluronic acid receptor, Extracellular link domain-containing protein 1, CRSBP-1, LYVE1, CRSBP1, HAR, Lymphatic vessel endothelial hyaluronic acid receptor 1
UniProt
Q9Y5Y7
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat